186 related articles for article (PubMed ID: 14990121)
21. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
Kawabuchi Y; Yamaguchi Y; Ohshita A; Minami K; Toge T
Anticancer Res; 2004; 24(2C):1193-200. PubMed ID: 15154646
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the expressed immunoglobulin IGHV repertoire in the New World marmoset Callithrix jacchus.
von Büdingen HC; Hauser SL; Nabavi CB; Genain CP
Immunogenetics; 2001 Sep; 53(7):557-63. PubMed ID: 11685468
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells.
Kiyoi H; Naoe T; Horibe K; Ohno R
J Clin Invest; 1992 Mar; 89(3):739-46. PubMed ID: 1541668
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin heavy chain variable gene utilization in human large cell and Burkitt's lymphoma cell lines.
Daley MD; Berinstein NL; Siminovitch KA
Clin Invest Med; 1994 Dec; 17(6):522-30. PubMed ID: 7895416
[TBL] [Abstract][Full Text] [Related]
25. A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
Matsueda S; Yamada A; Takao Y; Tamura M; Komatsu N; Yutani S; Ide T; Sata M; Itoh K
Cancer Immunol Immunother; 2007 Sep; 56(9):1359-66. PubMed ID: 17265020
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the intraclonal diversity of HLA-A0201-restricted T lymphocyte epitopes in follicular lymphoma idiotype.
Molinier-Frenkel V; Popa N; Poulot V; Chaise C; Marquet J; Haioun C; Gaulard P; Farcet JP; Delfau-Larue MH
Br J Haematol; 2006 Feb; 132(4):459-68. PubMed ID: 16412018
[TBL] [Abstract][Full Text] [Related]
27. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.
Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H
Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861
[TBL] [Abstract][Full Text] [Related]
28. Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells.
Dupont J; Latouche JB; Ma C; Sadelain M
Cancer Res; 2005 Jun; 65(12):5417-27. PubMed ID: 15958591
[TBL] [Abstract][Full Text] [Related]
29. Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28.
Han JF; Zhao TT; Liu HL; Lin ZH; Wang HM; Ruan ZH; Zou LY; Wu YZ
Cancer Immunol Immunother; 2006 Dec; 55(12):1575-83. PubMed ID: 16534571
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis.
Capello D; Martini M; Gloghini A; Cerri M; Rasi S; Deambrogi C; Rossi D; Spina M; Tirelli U; Larocca LM; Carbone A; Gaidano G
Haematologica; 2008 Aug; 93(8):1178-85. PubMed ID: 18556404
[TBL] [Abstract][Full Text] [Related]
31. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.
Azuma K; Sasada T; Takedatsu H; Shomura H; Koga M; Maeda Y; Yao A; Hirai T; Takabayashi A; Shichijo S; Itoh K
Clin Cancer Res; 2004 Oct; 10(19):6695-702. PubMed ID: 15475460
[TBL] [Abstract][Full Text] [Related]
32. Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
Wang Y; Takao Y; Harada M; Komatsu N; Ono T; Sata M; Itoh K; Yamada A
Cell Immunol; 2006 May; 241(1):38-46. PubMed ID: 16963008
[TBL] [Abstract][Full Text] [Related]
33. IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.
Belessi CJ; Davi FB; Stamatopoulos KE; Degano M; Andreou TM; Moreno C; Merle-Béral H; Crespo M; Laoutaris NP; Montserrat E; Caligaris-Cappio F; Anagnostopoulos AZ; Ghia P
Eur J Immunol; 2006 Jul; 36(7):1963-74. PubMed ID: 16783849
[TBL] [Abstract][Full Text] [Related]
34. Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice.
Boesen A; Sundar K; Coico R
Clin Diagn Lab Immunol; 2005 Oct; 12(10):1223-30. PubMed ID: 16210487
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia.
Maia S; Haining WN; Ansén S; Xia Z; Armstrong SA; Seth NP; Ghia P; den Boer ML; Pieters R; Sallan SE; Nadler LM; Cardoso AA
Cancer Res; 2005 Nov; 65(21):10050-8. PubMed ID: 16267031
[TBL] [Abstract][Full Text] [Related]
36. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
37. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
[TBL] [Abstract][Full Text] [Related]
38. Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody.
Chatterjee SK; Tripathi PK; Chakraborty M; Yannelli J; Wang H; Foon KA; Maier CC; Blalock JE; Bhattacharya-Chatterjee M
Cancer Res; 1998 Mar; 58(6):1217-24. PubMed ID: 9515808
[TBL] [Abstract][Full Text] [Related]
39. The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2.
Mitchell MS; Lund TA; Sewell AK; Marincola FM; Paul E; Schroder K; Wilson DB; Kan-Mitchell J
Cancer Immunol Immunother; 2007 Mar; 56(3):287-301. PubMed ID: 16874487
[TBL] [Abstract][Full Text] [Related]
40. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
Gu WY; Cao XS; Qiu GQ; Chen ZX; Sheng LX; Xie XB; He J; Cen JN; Shen HL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3475-80. PubMed ID: 16686063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
